Health and Healthcare
5864 Articles
Pfizer (PFE) reports on Friday, and just liketearing off a band-aid, investors are hoping the earnings release tobe quick, and…
Merck (MRK) announced what the market expected. On that note, they are already ahead of Yahoo!. Revenue hit $5.8 billion…
by H.S. AyoubBioHealth Investor.com
We can see the sweat on their brow, but all in all Merck (MRK) is running a pretty good race…
GlaxoSmithKline (GSK-NYSE/ADR) has just announced more positive data on its cervical cancer vaccine called CERVARIX(R). The company has said that…
Cell Genesys, Inc. (CEGE-NASDAQ) is trading up more than 7% at $5.50 in earlybird trading on thin volume this morning…
From BioHealth Investor
It’s always an interesting phenomenon when a large company becomes ultra-sensitive to news, as Boston Scientific (BSX) seems to be…
Peregrine Pharmaceuticals, Inc. (PPHM-NASDAQ) just issued a press release showing "Peregrine’s Selective Anti-VEGF Antibodies Inhibited Tumor Growth By 90% In…
Vertex (VRTX-NASDAQ) is seeing quite a bit of trading today ahead of a data presentation tomorrow. This one may have…
Merck’s new arthritis drug Arcoxia was rejected by an FDA panel by a vote of 20-to-1. Apparently, the drug has…
Cramer said in a video this afternoon on TheStreet.com that this Dendreon (DNDN-NASDAQ) is a classic case of short sellers…
Our top personal finance-related articles today. Your wallet will thank you later.